TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ARGX

argenx NV

Healthcare · Biotechnology

851.30$ -0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Income Statement

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,816 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARGX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
5.5 9.7 7.1 24 7.7 14 6.9 21 2.4 7.3 41 51 8.7 31 30 11 16 158 499 0.9 27 23 111 138 313 -258 511 330 758 401 902 573 1,346 791 948 1,127 3,206 1,298 2,816 8,446
-16 19 12 26 -38 27 19 35 22 47 87 78 1.0 118 168 75 121 274 0.0 307 1.4 272 10 381 -808 -456 36 574 43 43 59 665 81 111 109 340 121 279 850
5.5 -10 7.1 -1.7 7.7 45 6.9 -12 2.4 -39 41 -27 7.7 -87 -138 -63 -126 158 225 0.9 -277 22 459 128 -78 550 924 294 184 358 425 514 681 710 837 1,018 2,866 1,177 2,536 7,597
10 21 13 26 14 26 19 36 22 47 39 77 44 115 167 162 122 272 139 304 152 276 237 384 115 358 192 397 225 447 236 297 309 328 356 443 443 486 1,728
2.1 3.1 3.6 2.1 2.8 6.3 7.3 9.5 6.7 14 11 16 14 23 39 39 56 73 81 97 101 127 108 135 507 309 192 199 236 341 278 257 276 423 336 423 355 533 1,646
11 25 16 4.4 16 66 24 12 28 15 48 27 58 151 60 75 83 169 130 214 167 245 218 336 224 507 313 374 797 451 451 500 563 569 633 777 2,015 904 1,690 5,385
-5.9 -14 -9.0 -7.9 -8.1 -17 -17 -26 -26 -54 -6.8 -55 -49 -127 -206 -102 -280 0.0 95 -213 -457 -223 -397 -209 -341 43 -206 -81 -219 -93 -139 14 117 141 204 350 851 394 847 2,442
0.0 0.0 0.0 0.0 1.8 2.7 0.8 10 6.5 5.7 15 3.5 30 0.0 2.1 55 25 29 0.7 1.1 0.2 1.0 2.1 0.8 1.8 0.3 0.4 0.2 0.3 0.5 0.6 0.7 0.7 1.1 1.1 1.0 1.0 1.0 2.0 5.0
-5.9 -14 -9.0 -7.7 -9.9 -20 -22 -20 -19 -44 7.8 -62 -21 -114 -199 -157 -331 -29 76 -231 -474 -230 -447 -241 -303 56 -160 -83 -144 -74 -89 88 175 202 287 386 992 426 959 2,763
0.0 -0.4 0.0 0.6 0.0 -0.6 4.3 -0.6 0.0 -0.8 0.2 0.9 4.1 4.9 1.1 2.2 0.5 0.9 11 11 2.7 4.3 -2.9 11 -6.0 8.6 10 37 -11 27 -13 -57 -3.4 33 33 42 -55 119
-5.9 -13 -9.0 -14 -10.0 -17 -22 -17 -19 -39 7.6 -40 -25 -104 -179 -158 -255 -40 53 -234 -414 -227 -416 -235 -256 46 -113 -73 -156 -62 -33 91 866 169 245 344 1,047 366 839 2,596
-5.9 -13 -9.0 -5.7 -5.2 -14 -17 -22 -37 -60 -17 -47 -36 -126 -175 -157 -170 6.5 98 -212 -397 -222 -411 -201 -214 156 -183 -83 -38 -74 -21 89 127 203 288 1,009 864

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?